Protara Therapeutics (TARA) Current Assets (2013 - 2026)

Protara Therapeutics' Current Assets history runs 14 years deep, the most recent figure standing at $140.0 million for Q1 2026.

• In Q1 2026, Current Assets rose 10.64% year-over-year to $140.0 million; the TTM figure through Mar 2026 stood at $140.0 million (up 10.64% YoY), while the FY2025 annual figure was $159.5 million, down 7.35% from the prior year.
• Current Assets was $140.0 million for Q1 2026 at Protara Therapeutics, down from $159.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $172.2 million in Q4 2024 to a low of $57.9 million in Q1 2024.
• Historically, Current Assets has averaged $105.7 million across 5 years, with a median of $94.6 million in 2023.
• Biggest YoY gain for Current Assets was 150.57% in 2024; the steepest drop was 38.79% in 2024.
• A 5-year view of Current Assets shows it stood at $86.1 million in 2022, then declined by 20.25% to $68.7 million in 2023, then surged by 150.57% to $172.2 million in 2024, then decreased by 7.35% to $159.5 million in 2025, then declined by 12.23% to $140.0 million in 2026.
• The last three Current Assets figures came in at $140.0 million (Q1 2026), $159.5 million (Q4 2025), and $135.6 million (Q3 2025), per Business Quant data.